Literature DB >> 15381669

Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibition.

Erwin Bischoff, Johannes-Peter Stasch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15381669     DOI： 10.1161/01.CIR.0000142209.28862.12

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

Review 1.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

Review 2.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

Review 3.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

4.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

5.  FOXO3 is essential for CD44 expression in pancreatic cancer cells.

Authors:  M Kumazoe; M Takai; J Bae; S Hiroi; Y Huang; K Takamatsu; Y Won; M Yamashita; S Hidaka; S Yamashita; S Yamada; M Murata; S Tsukamoto; H Tachibana
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

Review 6.  Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.

Authors:  Johannes-Peter Stasch; Pál Pacher; Oleg V Evgenov
Journal:  Circulation       Date:  2011-05-24       Impact factor: 29.690

7.  Inhibition of phosphodiesterase 9A reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals.

Authors:  Lediana Iagalo Miguel; Camila B Almeida; Fabiola Traina; Andreia A Canalli; Venina M Dominical; Sara T O Saad; Fernando F Costa; Nicola Conran
Journal:  Inflamm Res       Date:  2011-02-20       Impact factor: 4.575

Review 8.  Modulation of cGMP in heart failure: a new therapeutic paradigm.

Authors:  Guido Boerrigter; Harald Lapp; John C Burnett
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  NOX1, 2, 4, 5: counting out oxidative stress.

Authors:  K Wingler; J J R Hermans; P Schiffers; Al Moens; M Paul; H H H W Schmidt
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 10.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.